Work

Prognostic value of circulating tumor DNA (ctDNA) detection by PhasED-Seq after axicabtagene ciloleucel (axi-cel) therapy in relapsed/refractory large B-cell lymphoma (LBCL).

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e15043

Authors: Brodie Miles, Daqin Mao, David M. Kurtz, Brian Sworder, Sierra Love Stowell, Hayley Warsinske, Saran Vardhanabhuti, Mike Mattie, Simone Filosto, Davide Bedognetti, Rhine Shen

Institutions: Kite (United States), Kite Pharma (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812155

FWCI:

Cites:

Cited by:

Related to: 10